L. Farhat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
L. Farhat has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
W. Mnejja
5 shared publications- Jamel Daoud
Service de radiothérapie carcinologique, Hôpital universitaire Habib Bourguiba, Sfax, Tunisia
4 shared publications - Wicem Siala
Department of Radiation Oncology, Habib Bourguiba University Hospital, Majida Boulila Road 3029, Sfax 3029, Tunisia
4 shared publications H. Daoud
3 shared publicationsJ. Daoud
3 shared publicationsT. Sahnoun
3 shared publications
Latest Publications
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 30
PO-060: Dose received by the pituitary gland during irradiation of nasopharyngeal carcinoma
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 30
PO-060: Dose received by the pituitary gland during irradiation of nasopharyngeal carcinoma
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 39-40
PO-083: Adaptative radiotherapy for nasopharyngeal carcinoma
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 39-40
PO-083: Adaptative radiotherapy for nasopharyngeal carcinoma
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 35
PO-071: Dose to the thyroid gland during irradiation of nasopharyngeal carcinoma
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 35
PO-071: Dose to the thyroid gland during irradiation of nasopharyngeal carcinoma
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 44
PO-092: Dosimetric comparaison of conformal and intensity modulated radiotherapy for locally recurrent NPC
- 1 March 2017
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 122, 44
PO-092: Dosimetric comparaison of conformal and intensity modulated radiotherapy for locally recurrent NPC
- 1 February 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S36
PO-085: Tongue Cancer After Radiotherapy for Nasopharyngeal Carcinoma. Three Cases Report and Literature Review
- 1 February 2013
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106, S36
PO-085: Tongue Cancer After Radiotherapy for Nasopharyngeal Carcinoma. Three Cases Report and Literature Review
- 13 April 2011
- Published by EDP Sciences in The European Physical Journal Applied Physics
- Vol. 54 (1) , 11001
In vivo dosimetry for head and neck carcinoma: determination of target absorbed dose from entrance and exit absorbed dose measurements
The aims of this work were to measure the entrance and exit dose for patient treated for head and neck tumors. The target absorbed dose was determined from the exit and entrance dose measurement. Twenty patients were evaluated. The results were compared to the calculated values and the midline dose was determinate and compared with the prescribed dose. 80 entrance doses and 80 exit doses measurements were performed. The average difference from expected values was 1.93% for entrance dose (SD 1.92%) and –0.34% for exit dose (SD 4.1%). The target absorbed dose differed from prescribed dose values by 2.94% (1.97%) for the results using the Noël method and 3.34% (SD: 2.29%) with the Rizzotti method. The total uncertainty budget in the measurement of the absorbed entrance and exit dose with diode, including diode reading, correction factors and diode calibration coefficient, is determined as 3.02% (1 s). Simple in vivo dose measurements are an additional safeguard against major setup errors and calculation or transcription errors that were missed during pre-treatment chart check.
- 13 April 2011
- Published by EDP Sciences in The European Physical Journal Applied Physics
- Vol. 54 (1) , 11001
In vivo dosimetry for head and neck carcinoma: determination of target absorbed dose from entrance and exit absorbed dose measurements
The aims of this work were to measure the entrance and exit dose for patient treated for head and neck tumors. The target absorbed dose was determined from the exit and entrance dose measurement. Twenty patients were evaluated. The results were compared to the calculated values and the midline dose was determinate and compared with the prescribed dose. 80 entrance doses and 80 exit doses measurements were performed. The average difference from expected values was 1.93% for entrance dose (SD 1.92%) and –0.34% for exit dose (SD 4.1%). The target absorbed dose differed from prescribed dose values by 2.94% (1.97%) for the results using the Noël method and 3.34% (SD: 2.29%) with the Rizzotti method. The total uncertainty budget in the measurement of the absorbed entrance and exit dose with diode, including diode reading, correction factors and diode calibration coefficient, is determined as 3.02% (1 s). Simple in vivo dose measurements are an additional safeguard against major setup errors and calculation or transcription errors that were missed during pre-treatment chart check.
- 1 January 2010
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 14 (1) , 69-73
Contrôle de qualité de la dose délivrée par mesures in vivo lors de la radiothérapie des tumeurs des voies aérodigestives supérieures
- 1 January 2010
- Published by Elsevier in Cancer/Radiothérapie
- Vol. 14 (1) , 69-73
Contrôle de qualité de la dose délivrée par mesures in vivo lors de la radiothérapie des tumeurs des voies aérodigestives supérieures